UPDATE: Meridian Bioscience, Inc. (VIVO) Misses Q2 EPS by 1c; Guides FY12 Below the Street

July 26, 2012 7:16 AM EDT Send to a Friend
Get Alerts VIVO Hot Sheet
Trade VIVO Now!
(Updated - July 26, 2012 7:17 AM EDT)

Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q2 EPS of $0.21, $0.01 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $46.54 million.

Looking for FY12 sales of $171-$175 million, which compares to the Street estimate of $182.7 million. The company reduced its EPS outlook to 78-81 cents, which compares to the Street estimate of 85 cents.

For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment